Articles by Melanie Sena - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Melanie Sena

Melanie Sena


Melanie Sena is community editor of Pharmaceutical Technology.

Articles
Novartis's Bexsero Receives FDA Breakthrough Therapy Designation
April 17, 2014

Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.

DepoVax Technology Selected for HPV–related Cancer Trials
April 17, 2014

Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.

EMA Warns of Falsified Herceptin Vials
April 16, 2014

EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.

PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

Center for Biologics Evaluation and Research Relocates
April 11, 2014

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

Desktop Human Body Developed for Toxicity Testing
April 10, 2014

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

uniQure Announces Management Changes
April 10, 2014

uniQure appoints a new COO and vice president, Medical affairs.

FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
April 10, 2014

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Lilly To Release Data Targeting Key Cancer Pathways At AACR 2014
April 7, 2014

Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.

ADVERTISEMENT

ADVERTISEMENT

Click here